Related references
Note: Only part of the references are listed.Hyper-Activation of Endogenous GLP-1 System to Gram-negative Sepsis Is Associated With Early Innate Immune Response and Modulated by Diabetes
Olga Bloch et al.
SHOCK (2021)
Persistently Elevated Glucagon-Like Peptide-1 Levels among Critically Ill Surgical Patients after Sepsis and Development of Chronic Critical Illness and Dismal Long-Term Outcomes
Scott C. Brakenridge et al.
JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2019)
GLP-1: Molecular mechanisms and outcomes of a complex signaling system
Nicholas K. Smith et al.
NEUROCHEMISTRY INTERNATIONAL (2019)
Renal Tubular Glucagon-Like Peptide-1 Receptor Expression Is Increased in Early Sepsis but Reduced in Chronic Kidney Disease and Sepsis-Induced Kidney Injury
Jae Hyun Choi et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The Glucagon-Like Peptide-1 Analog Exenatide Increases Blood Glucose Clearance, Lactate Clearance, and Heart Rate in Comatose Patients After Out-of-Hospital Cardiac Arrest
Sebastian Wiberg et al.
CRITICAL CARE MEDICINE (2018)
Sepsis-induced activation of endogenous GLP-1 system is enhanced in type 2 diabetes
Sivan H. Perl et al.
DIABETES-METABOLISM RESEARCH AND REVIEWS (2018)
Stimulation of the endogenous incretin glucose-dependent insulinotropic peptide by enteral dextrose improves glucose homeostasis and inflammation in murine endotoxemia
Faraaz Ali Shah et al.
TRANSLATIONAL RESEARCH (2018)
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
Melanie J. Davies et al.
DIABETES CARE (2018)
Effect of Hydrocortisone on Development of Shock Among Patients With Severe Sepsis: The HYPRESS Randomized Clinical Trial
John Michael Rague
JOURNAL OF EMERGENCY MEDICINE (2017)
Liraglutide and Renal Outcomes in Type 2 Diabetes
Johannes F. E. Mann et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Enteroendocrine L Cells Sense LPS after Gut Barrier Injury to Enhance GLP-1 Secretion
Lorene J. Lebrun et al.
CELL REPORTS (2017)
Glucagon-like peptide-1 receptor expression on human eosinophils and its regulation of eosinophil activation
P. D. Mitchell et al.
CLINICAL AND EXPERIMENTAL ALLERGY (2017)
The Effect of Short-Term Hyperglycemia on the Innate Immune System
Nagham Jafar et al.
AMERICAN JOURNAL OF THE MEDICAL SCIENCES (2016)
Trimeric PEG-Conjugated Exendin-4 for the Treatment of Sepsis
Wonhwa Lee et al.
BIOMACROMOLECULES (2016)
Glucagon-like peptide 1 improves insulin resistance in vitro through anti-inflammation of macrophages
C. Guo et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2016)
Assessment of Clinical Criteria for Sepsis For the Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Christopher W. Seymour et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)
Mervyn Singer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2016)
Anti-Inflammatory Effects of GLP-1-Based Therapies beyond Glucose Control
Young-Sun Lee et al.
MEDIATORS OF INFLAMMATION (2016)
Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes
Steven P. Marso et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
GLP-1R Agonists Modulate Enteric Immune Responses Through the Intestinal Intraepithelial Lymphocyte GLP-1R
Bernardo Yusta et al.
DIABETES (2015)
Cardioprotection Resulting from Glucagon-Like Peptide-1 Administration Involves Shifting Metabolic Substrate Utilization to Increase Energy Efficiency in the Rat Heart
Karpagam Aravindhan et al.
PLOS ONE (2015)
Effects of exendin-4, a glucagon like peptide-1 receptor agonist, on neutrophil count and inflammatory cytokines in a rat model of endotoxemia
Ofer Yanay et al.
JOURNAL OF INFLAMMATION RESEARCH (2015)
Radiation-induced oxidative injury of the ileum and colon is alleviated by glucagon-like peptide-1 and -2
Mustafa Deniz et al.
JOURNAL OF RADIATION RESEARCH AND APPLIED SCIENCES (2015)
GLP-1 Secretion Is Increased by Inflammatory Stimuli in an IL-6-Dependent Manner, Leading to Hyperinsulinemia and Blood Glucose Lowering
Florian Kahles et al.
DIABETES (2014)
GLP-1 Receptor Localization in Monkey and Human Tissue: Novel Distribution Revealed With Extensively Validated Monoclonal Antibody
Charles Pyke et al.
ENDOCRINOLOGY (2014)
Anti-diabetic actions of glucagon-like peptide-1 on pancreatic beta-cells
Young-Sun Lee et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2014)
Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action
Jonathan E. Campbell et al.
CELL METABOLISM (2013)
Exendin-4 inhibits iNOS expression at the protein level in LPS-stimulated Raw264.7 macrophage by the activation of cAMP/PKA pathway
Seo-Yoon Chang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2013)
Glucagon-Like Peptide-1 (GLP-1): Effect on Kidney Hemodynamics and Renin-Angiotensin-Aldosterone System in Healthy Men
Jeppe Skov et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Pancreatic β Cell Dedifferentiation as a Mechanism of Diabetic β Cell Failure
Chutima Talchai et al.
CELL (2012)
Mild hypoglycemia is independently associated with increased risk of mortality in patients with sepsis: a 3-year retrospective observational study
Sunghoon Park et al.
CRITICAL CARE (2012)
DPP4 inhibition improves functional outcome after renal ischemia-reperfusion injury
Lorenzo L. F. Glorie et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2012)
Exendin-4, a glucagon-like peptide-1 receptor agonist, provides neuroprotection in mice transient focal cerebral ischemia
Shinichiro Teramoto et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2011)
Inhibition of Monocyte Adhesion to Endothelial Cells and Attenuation of Atherosclerotic Lesion by a Glucagon-like Peptide-1 Receptor Agonist, Exendin-4
Masayuki Arakawa et al.
DIABETES (2010)
Effects of Acute Hypoglycemia on Inflammatory and Pro-atherothrombotic Biomarkers in Individuals With Type 1 Diabetes and Healthy Individuals
Nino Gogitidze Joy et al.
DIABETES CARE (2010)
Effects of Acute Insulin-Induced Hypoglycemia on Indices of Inflammation Putative mechanism for aggravating vascular disease in diabetes
Rohana J. Wright et al.
DIABETES CARE (2010)
被撤回的出版物: A glucagon-like peptide-1 (GLP-1) analogue, liraglutide, upregulates nitric oxide production and exerts anti-inflammatory action in endothelial cells (Retracted article. See vol. 55, pg. 533, 2012)
Y. Hattori et al.
DIABETOLOGIA (2010)
Glucagon-like peptide-1 receptor signalling selectively regulates murine lymphocyte proliferation and maintenance of peripheral regulatory T cells
I. Hadjiyanni et al.
DIABETOLOGIA (2010)
GLP-1 signaling preserves cardiac function in endotoxemic Fischer 344 and DPP4-deficient rats
Hui-Chun Ku et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2010)
Prevalence, incidence, and clinical resolution of insulin resistance in critically ill patients: An observational study
Farzad Saberi et al.
JOURNAL OF PARENTERAL AND ENTERAL NUTRITION (2008)
Dipeptidyl peptidase IV inhibition downregulates Na+-H+ exchanger NHE3 in rat renal proximal tubule
Adriana Castello Costa Girardi et al.
AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY (2008)
The impact of the severity of sepsis on the risk of hypoglycaemia and glycaemic variability
Reiner M. Waeschle et al.
CRITICAL CARE (2008)
The physiology of glucagon-like peptide 1
Jens Juul Holst
PHYSIOLOGICAL REVIEWS (2007)
Interleukin-1 beta-induced insulin resistance in adipocytes through down-regulation of insulin receptor substrate-1 expression
Jennifer Jager et al.
ENDOCRINOLOGY (2007)
Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans
J Schirra et al.
GUT (2006)
Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion
LA Nikolaidis et al.
CIRCULATION (2004)
Sensory nerves contribute to insulin secretion by glucagon-like peptide-1 in mice
B Ahrén
AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY (2004)
Epac: A new cAMP-binding protein in support of glucagon-like peptide-1 receptor-mediated signal transduction in the pancreatic beta-cell
GG Holz
DIABETES (2004)
Naturally arising CD4(+) regulatory T cells for immunologic self-tolerance and negative control of immune responses
S Sakaguchi
ANNUAL REVIEW OF IMMUNOLOGY (2004)
International union of pharmacology.: XXXV.: The glucagon receptor family
KE Mayo et al.
PHARMACOLOGICAL REVIEWS (2003)
Association between hyperglycemia and increased hospital mortality in a heterogeneous population of critically ill patients
JS Krinsley
MAYO CLINIC PROCEEDINGS (2003)
Epinephrine inhibits insulin-stimulated muscle glucose transport
DG Hunt et al.
JOURNAL OF APPLIED PHYSIOLOGY (2002)
Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes:: a parallel-group study
M Zander et al.
LANCET (2002)
NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1
MC Lawrence et al.
DIABETES (2002)
Different domains in the third intracellular loop of the GLP-1 receptor are responsible for Gαs and Gαi/Gαo activation
M Hällbrink et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEIN STRUCTURE AND MOLECULAR ENZYMOLOGY (2001)
Share Paper
